Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.

Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Abstract Text:

    takashi kobayashiTakashi Kobayashi,rei gotoRei Goto,tsuguya fukuiTsuguya Fukui,osamu ogawaOsamu Ogawa,takashi kobayashiTakashi Kobayashi,rei gotoRei Goto,tsuguya fukuiTsuguya Fukui,osamu ogawaOsamu Ogawa,

    OBJECTIVES: Improvement in the specificity of primary screening tests, without significant cost elevation of the assay, provides cost savings in prostate cancer screening programs by reducing unnecessary secondary screening procedures. The purpose of this study was to evaluate the economic impact of improvement in the specificity of primary screening tests and to estimate the socially acceptable cost elevation for improved specificity. METHODS: A decision-analytic model was designed to evaluate the total costs of prostate cancer mass screening according to the changes in the specificity and the cost of the primary screening test. All assumed factors were tested by three-way sensitivity analyses incorporating cost and specificity. RESULTS: The base case analysis showed that a 1% improvement in the specificity of the primary screening test provides a $1.19 cost reduction per participant. Sensitivity analyses showed that an acceptable cost elevation for a 1% improvement in the specificity ranged from 0.68 to 2.90 $/% with respect to changes in several factors in the screening program. CONCLUSIONS: The specificity and cost of the primary screening test has a significant economical impact on prostate cancer mass screening. For each screening program, it should be taken into consideration whether the cost of the new test deserves the specificity.

    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Publishing Authors By Initials

    t kobayashiT Kobayashi,r gotoR Goto,t fukuiT Fukui,o ogawaO Ogawa,t kobayashiT Kobayashi,r gotoR Goto,t fukuiT Fukui,o ogawaO Ogawa,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of urology : official journa

    VOLUME: 14

    Page Numbers: 805-10

    Journal Abbreviation: Int. J. Urol.

    ISSN: 0919-8172

    DAY: 31

    MONTH: Sep

    YEAR: 2007

    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9440237

    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.

    AFFILIATION: Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Tokyo, Japan.

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Urol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News